AI Insights · Timothy · July 2025
Top Health and Fitness Apps in Oman Q2 2025: Performance Insights
Explore the performance trends of the top health and fitness apps in Oman during Q2 2025, with data from Sensor Tower highlighting downloads, revenue, and active users.
In the second quarter of 2025, the health and fitness app landscape in Oman saw varied performance across the leading applications, as reported by Sensor Tower.
Flo Cycle & Period Tracker experienced a notable peak in weekly revenue, reaching approximately $1.5K at the end of April. Despite fluctuations, downloads remained relatively stable, with a slight increase in June, peaking at 833. Active users hovered around 18K, with a small dip and subsequent recovery by the quarter's end.
MyFitnessPal: Calorie Counter showed a gradual increase in both revenue and downloads towards the end of the quarter. Revenue peaked at about $1K in late June, while downloads saw a steady rise, culminating in 601 by the end of the quarter. Active users increased consistently, reaching around 6.5K.
Cal AI - Calorie Tracker demonstrated a strong start in revenue, peaking at $1.1K in mid-April, before stabilizing at lower levels. Downloads showed a sharp rise initially, reaching 1.1K in early April, before settling around 300. Active users remained steady, averaging around 1.5K throughout the quarter.
Mezan ميزان saw significant fluctuations in downloads, with a high of 1K at the end of April. Revenue also varied, peaking at $778 in late June. Active users, however, declined steadily, dropping from over 1K to just over 150 by the quarter's end.
Strava: Run, Bike, Walk maintained a consistent revenue stream, with several peaks above $500. Downloads increased gradually, reaching 360 in late June. Active users grew steadily, climbing from 4K to over 5K by the end of the quarter.
These insights reflect the dynamic nature of the health and fitness app market in Oman, with varying trends across downloads, revenue, and user engagement. For more detailed analysis, visit Sensor Tower.